Dudediligence.

Skye Bioscience, Inc

SKYENASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Agreement endedSep 11 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: CRNX, TYRA, ALEC→

From the filings

Figures

Net income
−$50.5Mlast 12 months
Operating cash flow
−$42.4Mlast 12 months
Cash and equivalents
$8.1Mat the last balance sheet
Shares outstanding
35.1M shareson issue
Every year and quarter →